Association of Glucose Concentrations at Hospital Discharge With Readmissions and Mortality: A Nationwide Cohort Study

Author:

Spanakis Elias K12ORCID,Umpierrez Guillermo E3,Siddiqui Tariq24,Zhan Min5,Snitker Soren26,Fink Jeffrey C64,Sorkin John D7

Affiliation:

1. Division of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland

2. Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland

3. Division of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, Georgia

4. Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland

5. Department of Epidemiology and Public Health, University of Maryland, Baltimore, Maryland

6. Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland

7. Baltimore Veterans Affairs Medical Center Geriatric Research, Education, and Clinical Center, Baltimore, Maryland

Abstract

Abstract Context Low blood glucose concentrations during the discharge day may affect 30-day readmission and posthospital discharge mortality rates. Objective To investigate whether patients with diabetes and low glucose values during the last day of hospitalization are at increased risk of readmission or mortality. Design and Outcomes Minimum point of care glucose values were collected during the last 24 hours of hospitalization. We used adjusted rates of 30-day readmission rate, 30-, 90-, and 180-day mortality rates, and combined 30-day readmission/mortality rate to identify minimum glucose thresholds above which patients can be safely discharged. Patients and Setting Nationwide cohort study including 843,978 admissions of patients with diabetes at the Veteran Affairs hospitals 14 years. Results The rate ratios (RRs) increased progressively for all five outcomes as the minimum glucose concentrations progressively decreased below the 90 to 99 mg/dL category, compared with the 100 to 109 mg/dL category: 30-day readmission RR, 1.01 to 1.45; 30-day readmission/mortality RR, 1.01 to 1.71; 30-day mortality RR, 0.99 to 5.82; 90-day mortality RR, 1.01 to 2.40; 180-day mortality RR, 1.03 to 1.91. Patients with diabetes experienced greater 30-day readmission rates, 30-, 90- and 180-day postdischarge mortality rates, and higher combined 30-day readmission/mortality rates, with glucose levels <92.9 mg/dL, <45.2 mg/dL, 65.8 mg/dL, 67.3 mg/dL, and <87.2 mg/dL, respectively. Conclusion Patients with diabetes who had hypoglycemia or near-normal glucose values during the last day of hospitalization had higher rates of 30-day readmission and postdischarge mortality.

Funder

U.S. Department of Veterans Affairs (US)

Baltimore VA Patient Safety Center of Inquiry

U.S. Public Health Service

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Aging

Baltimore VA Geriatric Research, Education, and Clinical Center

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3